81_FR_12769 81 FR 12722 - Uniform Formulary Beneficiary Advisory Panel; Notice of Federal Advisory Committee Meeting

81 FR 12722 - Uniform Formulary Beneficiary Advisory Panel; Notice of Federal Advisory Committee Meeting

DEPARTMENT OF DEFENSE
Office of the Secretary

Federal Register Volume 81, Issue 47 (March 10, 2016)

Page Range12722-12722
FR Document2016-05381

The Department of Defense is publishing this notice to announce a Federal Advisory Committee meeting of the Uniform Formulary Beneficiary Advisory Panel (hereafter referred to as the Panel).

Federal Register, Volume 81 Issue 47 (Thursday, March 10, 2016) 
[Federal Register Volume 81, Number 47 (Thursday, March 10, 2016)]
[Notices]
[Page 12722]
From the Federal Register Online  [www.thefederalregister.org]
[FR Doc No: 2016-05381]


-----------------------------------------------------------------------

DEPARTMENT OF DEFENSE

Office of the Secretary


Uniform Formulary Beneficiary Advisory Panel; Notice of Federal 
Advisory Committee Meeting

AGENCY: Assistant Secretary of Defense (Health Affairs), DoD.

ACTION: Notice of meeting.

-----------------------------------------------------------------------

SUMMARY: The Department of Defense is publishing this notice to 
announce a Federal Advisory Committee meeting of the Uniform Formulary 
Beneficiary Advisory Panel (hereafter referred to as the Panel).

DATES: Wednesday, April 6, 2016, from 9:00 a.m. to 12:00 p.m.

ADDRESSES: Naval Heritage Center Theater, 701 Pennsylvania Avenue NW., 
Washington, DC 20004.

FOR FURTHER INFORMATION CONTACT: CAPT Edward Norton, DFO, Uniform 
Formulary Beneficiary Advisory Panel, 7700 Arlington Boulevard, Suite 
5101, Falls Church, VA 22042-5101. Telephone: (703) 681-2890. Fax: 
(703) 681-1940. Email Address: [email protected].

SUPPLEMENTARY INFORMATION: This meeting is being held under the 
provisions of the Federal Advisory Committee Act of 1972 (Title 5, 
United States Code (U.S.C.), Appendix, as amended) and the Government 
in the Sunshine Act of 1976 (5 U.S.C. 552b, as amended).
    Purpose of Meeting: The Panel will review and comment on 
recommendations made to the Director of Defense Health Agency, by the 
Pharmacy and Therapeutics Committee, regarding the Uniform Formulary.

Meeting Agenda

1. Sign-In
2. Welcome and Opening Remarks
3. Public Citizen Comments
4. Scheduled Therapeutic Class Reviews (Comments will follow each 
agenda item)
    a. Oral Contraceptives
    b. Antifungal Agents--Subclass--Topical Lacquers
    c. Ophthalmic Anti-Inflammatory/Immunomodulatory Agents: Ophthalmic 
Immunomodulatory Agent
5. Designated Newly Approved Drugs in Already-Reviewed Classes
6. Designated Newly FDA Approved Drugs
7. Pertinent Utilization Management Issues
8. Panel Discussions and Vote

    Meeting Accessibility: Pursuant to 5 U.S.C. 552b, as amended, and 
41 Code of Federal Regulations (CFR) 102-3.140 through 102-3.165, and 
the availability of space, this meeting is open to the public. Seating 
is limited and will be provided only to the first 220 people signing-
in. All persons must sign-in legibly.
    Administrative Work Meeting: Prior to the public meeting, the Panel 
will conduct an Administrative Work Meeting from 8:30 a.m. to 9:00 a.m. 
to discuss administrative matters of the Panel. The Administrative Work 
Meeting will be held at the Naval Heritage Center, 701 Pennsylvania 
Avenue NW., Washington, DC 20004. Pursuant to 41 CFR 102-3.160, the 
Administrative Work Meeting will be closed to the public.
    Written Statements: Pursuant to 41 CFR 102-3.140, the public or 
interested organizations may submit written statements to the 
membership of the Panel at any time or in response to the stated agenda 
of a planned meeting. Written statements should be submitted to the 
Panel's Designated Federal Officer (DFO). The DFO's contact information 
can be obtained from the General Services Administration's Federal 
Advisory Committee Act Database at http://facadatabase.gov/.
    Written statements that do not pertain to the scheduled meeting of 
the Panel may be submitted at any time. However, if individual comments 
pertain to a specific topic being discussed at a planned meeting, then 
these statements must be submitted no later than 5 business days prior 
to the meeting in question. The DFO will review all submitted written 
statements and provide copies to all the committee members.
    Public Comments: In addition to written statements, the Panel will 
set aside 1 hour for individuals or interested groups to address the 
Panel. To ensure consideration of their comments, individuals and 
interested groups should submit written statements as outlined in this 
notice; but if they still want to address the Panel, then they will be 
afforded the opportunity to register to address the Panel. The Panel's 
DFO will have a ``Sign-Up Roster'' available at the Panel meeting for 
registration on a first-come, first-serve basis. Those wishing to 
address the Panel will be given no more than 5 minutes to present their 
comments, and at the end of the 1-hour time period, no further public 
comments will be accepted. Anyone who signs-up to address the Panel, 
but is unable to do so due to the time limitation, may submit their 
comments in writing; however, they must understand that their written 
comments may not be reviewed prior to the Panel's deliberation.
    To ensure timeliness of comments for the official record, the Panel 
encourages that individuals and interested groups consider submitting 
written statements instead of addressing the Panel.

    Dated: March 7, 2016.
Aaron Siegel,
Alternate OSD Federal Register Liaison Officer, Department of Defense.
[FR Doc. 2016-05381 Filed 3-9-16; 8:45 am]
 BILLING CODE 5001-06-P

12722 Federal Register / Vol. 81, No. 47 / Thursday, March 10, 2016 / Notices General Services Administration post- Advisory Panel (hereafter referred to as Heritage Center, 701 Pennsylvania shipment audit or carrier freight bills. the Panel). Avenue NW., Washington, DC 20004. Affected Public: Business or other for- DATES: Wednesday, April 6, 2016, from Pursuant to 41 CFR 102–3.160, the profit. 9:00 a.m. to 12:00 p.m. Administrative Work Meeting will be Frequency: On occasion. ADDRESSES: Naval Heritage Center closed to the public. Respondent’s Obligation: Required to Theater, 701 Pennsylvania Avenue NW., Written Statements: Pursuant to 41 obtain or retain benefits. Washington, DC 20004. CFR 102–3.140, the public or interested OMB Desk Officer: Ms. Jasmeet organizations may submit written FOR FURTHER INFORMATION CONTACT: Seehra. statements to the membership of the Comments and recommendations on CAPT Edward Norton, DFO, Uniform Panel at any time or in response to the the proposed information collection Formulary Beneficiary Advisory Panel, stated agenda of a planned meeting. should be emailed to Ms. Jasmeet 7700 Arlington Boulevard, Suite 5101, Written statements should be submitted Seehra, DoD Desk Officer, at Oira_ Falls Church, VA 22042–5101. to the Panel’s Designated Federal Officer submission@omb.eop.gov. Please Telephone: (703) 681–2890. Fax: (703) (DFO). The DFO’s contact information identify the proposed information 681–1940. Email Address: can be obtained from the General collection by DoD Desk Officer and the dha.ncr.health-it.mbx.baprequests@ Services Administration’s Federal Docket ID number and title of the mail.mil. Advisory Committee Act Database at information collection. SUPPLEMENTARY INFORMATION: This http://facadatabase.gov/. You may also submit comments and meeting is being held under the Written statements that do not pertain recommendations, identified by Docket provisions of the Federal Advisory to the scheduled meeting of the Panel ID number and title, by the following Committee Act of 1972 (Title 5, United may be submitted at any time. However, method: States Code (U.S.C.), Appendix, as if individual comments pertain to a • Federal eRulemaking Portal: http:// amended) and the Government in the specific topic being discussed at a www.regulations.gov. Follow the Sunshine Act of 1976 (5 U.S.C. 552b, as planned meeting, then these statements instructions for submitting comments. amended). must be submitted no later than 5 Instructions: All submissions received Purpose of Meeting: The Panel will business days prior to the meeting in must include the agency name, Docket review and comment on question. The DFO will review all ID number and title for this Federal recommendations made to the Director submitted written statements and Register document. The general policy of Defense Health Agency, by the provide copies to all the committee for comments and other submissions Pharmacy and Therapeutics Committee, members. from members of the public is to make regarding the Uniform Formulary. Public Comments: In addition to these submissions available for public written statements, the Panel will set Meeting Agenda viewing on the Internet at http:// aside 1 hour for individuals or www.regulations.gov as they are 1. Sign-In interested groups to address the Panel. received without change, including any 2. Welcome and Opening Remarks To ensure consideration of their personal identifiers or contact 3. Public Citizen Comments comments, individuals and interested information. 4. Scheduled Therapeutic Class Reviews groups should submit written DOD Clearance Officer: Mr. Frederick (Comments will follow each agenda statements as outlined in this notice; but Licari. item) if they still want to address the Panel, Written requests for copies of the a. Oral Contraceptives then they will be afforded the information collection proposal should b. Antifungal Agents—Subclass— opportunity to register to address the be sent to Mr. Licari at WHS/ESD Topical Lacquers Panel. The Panel’s DFO will have a Directives Division, 4800 Mark Center c. Ophthalmic Anti-Inflammatory/ ‘‘Sign-Up Roster’’ available at the Panel Drive, East Tower, Suite 02G09, Immunomodulatory Agents: meeting for registration on a first-come, Alexandria, VA 22350–3100. Ophthalmic Immunomodulatory first-serve basis. Those wishing to Agent Dated: March 7, 2016. address the Panel will be given no more 5. Designated Newly Approved Drugs in Aaron Siegel, than 5 minutes to present their Already-Reviewed Classes Alternate OSD Federal Register Liaison 6. Designated Newly FDA Approved comments, and at the end of the 1-hour Officer, Department of Defense. Drugs time period, no further public [FR Doc. 2016–05363 Filed 3–9–16; 8:45 am] 7. Pertinent Utilization Management comments will be accepted. Anyone Issues who signs-up to address the Panel, but BILLING CODE 5001–06–P 8. Panel Discussions and Vote is unable to do so due to the time limitation, may submit their comments Meeting Accessibility: Pursuant to 5 DEPARTMENT OF DEFENSE in writing; however, they must U.S.C. 552b, as amended, and 41 Code understand that their written comments of Federal Regulations (CFR) 102–3.140 Office of the Secretary may not be reviewed prior to the Panel’s through 102–3.165, and the availability deliberation. of space, this meeting is open to the To ensure timeliness of comments for Uniform Formulary Beneficiary public. Seating is limited and will be the official record, the Panel encourages Advisory Panel; Notice of Federal provided only to the first 220 people that individuals and interested groups Advisory Committee Meeting signing-in. All persons must sign-in consider submitting written statements mstockstill on DSK4VPTVN1PROD with NOTICES AGENCY: Assistant Secretary of Defense legibly. instead of addressing the Panel. (Health Affairs), DoD. Administrative Work Meeting: Prior to the public meeting, the Panel will Dated: March 7, 2016. ACTION: Notice of meeting. conduct an Administrative Work Aaron Siegel, SUMMARY: The Department of Defense is Meeting from 8:30 a.m. to 9:00 a.m. to Alternate OSD Federal Register Liaison publishing this notice to announce a discuss administrative matters of the Officer, Department of Defense. Federal Advisory Committee meeting of Panel. The Administrative Work [FR Doc. 2016–05381 Filed 3–9–16; 8:45 am] the Uniform Formulary Beneficiary Meeting will be held at the Naval BILLING CODE 5001–06–P VerDate Sep<11>2014 17:55 Mar 09, 2016 Jkt 238001 PO 00000 Frm 00043 Fmt 4703 Sfmt 9990 E:\FR\FM\10MRN1.SGM 10MRN1


Document Created: 2018-02-02 15:12:19
Document Modified: 2018-02-02 15:12:19
CategoryRegulatory Information
CollectionFederal Register
sudoc ClassAE 2.7:
GS 4.107:
AE 2.106:
PublisherOffice of the Federal Register, National Archives and Records Administration
SectionNotices
ActionNotice of meeting.
DatesWednesday, April 6, 2016, from 9:00 a.m. to 12:00 p.m.
ContactCAPT Edward Norton, DFO, Uniform Formulary Beneficiary Advisory Panel, 7700 Arlington Boulevard, Suite 5101, Falls Church, VA 22042-5101. Telephone: (703) 681-2890. Fax:
FR Citation81 FR 12722 
2025 Federal Register | Disclaimer | Privacy Policy
USC | CFR | eCFR